Medtech merger and acquisition deal announcements slowed in the first half of 2019, but the industry got a boost from Verily’s $1 billion round of funding — the largest ever for a medtech firm. The Verily round was twice the size of the biggest-ever VC deal for a biotech company, according to the Vantage Half-Year […]
Exact Sciences is successful: Here are the secrets that helped it grow
Kevin Conroy knew he was taking a risk when he became CEO of Exact Sciences: The company had twice failed to develop screening tests for colorectal cancer, and it was light on cash. But as he explained in a recent LinkedIn blog post, he had three friends diagnosed with colorectal cancer around the same time: “While […]
Phillips-Medisize’s increased business to benefit Molex plant in Arkansas
Phillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark. Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader in consumable […]
Medtech stocks: the best and worst of Q1 2017
More than four-fifths of the 100 largest medical device companies in the world saw their stock prices increase during the first three months of 2017, according to a Medical Design & Outsourcing analysis of how the stocks of our Big 100 companies are faring. The situation suggests that even with the uncertainty around what the […]
New blood-based test could detect all lung cancer types
Exact Sciences and the Mayo Clinic recently collaborated on a blood-based lung cancer test that researchers say has shown high accuracy for detecting all stages of lung cancer. “These results reveal an opportunity to detect lung cancer from a simple blood draw,” said Kevin Conroy, chairman and CEO of Exact Sciences, in a news release. “Our […]
MassDevice Network
@MassDevice
LinkedIn
YouTube